These changes in CKD patients are due to alterations in the peripheral 5′-monodeiodination of T4, reduced levels of plasma proteins that bind T4, the presence of inhibitors of T4 binding to plasma proteins, metabolic acidosis, and effects of medications18. This evidence concerns the gene CD4 and chronic kidney disease.